Stay updated on T-DM1 & Tucatinib in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the T-DM1 & Tucatinib in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DM1 & Tucatinib in HER2+ Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now displays an updated UI/release revision label (Revision: v3.5.3 instead of v3.5.2), reflecting a site/version update rather than a change to the underlying study record.
    Difference
    0.1%
    Check dated 2026-04-25T18:45:15.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and Deleted Revision: v3.5.0 from the record history.
    Difference
    0.1%
    Check dated 2026-04-18T13:36:15.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    46 days ago
    Change Detected
    Summary
    Added revision v3.5.0 and removed revision v3.4.3 from the record history.
    Difference
    0.1%
    Check dated 2026-03-21T00:47:27.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed from the record history.
    Difference
    0.1%
    Check dated 2026-03-06T19:43:06.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    A new revision entry v3.4.2 was added to the study record history, and the previous revision v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:43:06.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added and Revision: v3.4.0 was removed from the history.
    Difference
    0.1%
    Check dated 2026-02-06T09:13:10.000Z thumbnail image

Stay in the know with updates to T-DM1 & Tucatinib in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DM1 & Tucatinib in HER2+ Breast Cancer Clinical Trial page.